Leap Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GILEAD SCIENCES, INC. | 05/13/2025 | 5.32 M | $1.62 M | 0.00% | 12.89% |
SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 2.44 M | $745.16 K | 0.00% | 5.92% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.45 M | $442.36 K | 7.40% | 3.51% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 1.28 M | $389.00 K | 470.43% | 3.10% |
VANGUARD GROUP INC | 05/09/2025 | 1.18 M | $358.56 K | -1.29% | 2.85% |
MONACO ASSET MANAGEMENT SAM | 05/08/2025 | 1.05 M | $320.36 K | 410.02% | 2.54% |
SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 950.97 K | $290.14 K | 0.52% | 2.30% |
LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 709.22 K | $216.38 K | 0.00% | 1.72% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 404.74 K | $123.49 K | -65.47% | 0.98% |
KEY CLIENT FIDUCIARY ADVISORS, LLC | 04/10/2025 | 388.72 K | $118.60 K | 7.60% | 0.94% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 304.11 K | $92.85 K | -8.24% | 0.74% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 290.04 K | $88.49 K | 28.29% | 0.70% |
BLACKROCK, INC. | 05/02/2025 | 201.67 K | $61.53 K | -11.17% | 0.49% |
STATE STREET CORP | 05/15/2025 | 125.61 K | $38.33 K | 0.00% | 0.30% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 111.00 K | $33.87 K | 4.72% | 0.27% |
CITADEL ADVISORS LLC | 05/15/2025 | 62.80 K | $19.16 K | 554.17% | 0.15% |
NORTHERN TRUST CORP | 05/13/2025 | 61.61 K | $18.80 K | 0.00% | 0.15% |
LPL FINANCIAL LLC | 05/07/2025 | 53.36 K | $16.28 K | -29.60% | 0.13% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 50.50 K | $15.41 K | -3.81% | 0.12% |
CITADEL ADVISORS LLC | 05/15/2025 | 30.40 K | $9.28 K | 162.07% | 0.07% |
BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 05/20/2025 | 29.21 K | $8.91 K | 100.00% | 0.07% |
BARCLAYS PLC | 05/15/2025 | 28.82 K | $9.00 K | 100.00% | 0.07% |
DRW SECURITIES, LLC | 05/15/2025 | 28.16 K | $8.59 K | 100.00% | 0.07% |
SCIENTECH RESEARCH LLC | 05/15/2025 | 20.74 K | $6.33 K | 100.00% | 0.05% |
BAIRD FINANCIAL GROUP, INC. | 05/15/2025 | 20.00 K | $6.10 K | -30.80% | 0.05% |
WARBERG ASSET MANAGEMENT LLC | 05/09/2025 | 15.00 K | $4.58 K | 100.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 14.20 K | $4.40 K | 100.00% | 0.03% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 12.84 K | $3.92 K | 100.00% | 0.03% |
BLAIR WILLIAM & CO/IL | 05/09/2025 | 10.00 K | $3.05 K | 0.00% | 0.02% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 3.31 K | $1.01 K | -9.03% | 0.01% |
CNB BANK | 04/24/2025 | 3.00 K | $915 | 100.00% | 0.01% |
ROYAL BANK OF CANADA | 05/15/2025 | 2.74 K | $1.00 K | -58.55% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 1.88 K | $582 | -53.03% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 1.50 K | $458 | 100.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 05/14/2025 | 1.50 K | $402 | 0.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 1.21 K | $367 | -14.66% | 0.00% |
HUNTINGTON NATIONAL BANK | 05/14/2025 | 1.00 K | $305 | 100.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 1.00 K | $291 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 259 | $79 | 5.28% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 227 | $69 | 0.00% | 0.00% |
TOMPKINS FINANCIAL CORP | 04/07/2025 | 120 | $37 | 0.00% | 0.00% |
ALLWORTH FINANCIAL LP | 04/30/2025 | 115 | $46 | 0.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 05/15/2025 | 82 | $25 | -99.84% | 0.00% |
FINANCIAL MANAGEMENT PROFESSIONALS, INC. | 04/10/2025 | 20 | $6 | 100.00% | 0.00% |
CALDWELL SUTTER CAPITAL, INC. | 04/16/2025 | 4 | $1 | 0.00% | 0.00% |
US BANCORP \DE\ | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
UBS OCONNOR LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Leap Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Leap Therapeutics, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 5.32 M
Samsara BioCapital, LLC: 2.44 M
683 Capital Management, LLC: 1.45 M
ACADIAN ASSET MANAGEMENT LLC: 1.28 M
VANGUARD GROUP INC: 1.18 M
Monaco Asset Management SAM: 1.05 M
40.45% of Leap Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16.99 M shares in the last 24 months. This purchase volume represents approximately $6.42 M in transactions.